Sign in to view content

Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch

Estephania Feria, MD

Video
Published 2019

Related

Natural History of Untreated Atrophic Lesions in AMD and Stargardt Disease: A Meta-analysis
Lucian V. Del Priore, MD, PhD
On Demand Cases, Courses, and Papers
2019
Protocol T Extension Results
John A. Wells, MD, FACS
Updates from the Field
2019
Foveal Capillary Perfusion Density Decreases in Diabetics with DME Treated on a Fixed Regimen of Intravitreal Aflibercept Injections Over 24 Months
Brittney Statler, MD
Updates from the Field
2020

Category: AMD-Neovascular

See more